Skip to main content
. 2024 Dec 2;14:1453246. doi: 10.3389/fonc.2024.1453246

Figure 1.

Figure 1

Bi-directional two-sample Mendelian randomization analysis. (A) Forward analysis: The exposure is blood and urine biomarkers, and the outcome is lung cancer. (B) Reverse analysis: The exposure is lung cancer, and the outcome is blood and urine biomarkers.